BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2449990)

  • 21. Transforming growth factor-beta 1 proliferated vascular smooth muscle cells from spontaneously hypertensive rats.
    Sato M; Ohsaki Y; Tobise K
    Am J Hypertens; 1995 Feb; 8(2):160-6. PubMed ID: 7755944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular structure and smooth muscle contractility in experimental hypertension.
    Mulvany MJ
    J Cardiovasc Pharmacol; 1987; 10 Suppl 6():S79-85. PubMed ID: 2485033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An examination of the arterial media in transplanted arteries of spontaneously hypertensive (SHR) and normotensive Wistar Kyoto rats (WKY).
    Pang SC; Scott TM
    Artery; 1985; 12(6):382-7. PubMed ID: 4051757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional disturbance of the cell membrane in hypertension.
    Swales JD
    J Hypertens Suppl; 1990 Dec; 8(7):S203-11. PubMed ID: 2095390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dysfunction of calcium handling by smooth muscle in hypertension.
    Kwan CY
    Can J Physiol Pharmacol; 1985 Apr; 63(4):366-74. PubMed ID: 3159469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in sodium pump activity and vascular contraction.
    Mulvany MJ
    J Hypertens; 1985 Oct; 3(5):429-36. PubMed ID: 2415577
    [No Abstract]   [Full Text] [Related]  

  • 27. Calcium and vascular smooth muscle membrane in hypertension.
    Furspan PB; Lamb FS; Ross PV; Webb RC; Bohr DF
    Prog Clin Biol Res; 1986; 219():225-43. PubMed ID: 2431415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular muscle membrane cation mechanisms and total peripheral resistance.
    Hermsmeyer RK
    Hypertension; 1987 Nov; 10(5 Pt 2):I20-2. PubMed ID: 2445679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early structural changes in precapillary vessels in hypertension and their relationship to functional changes.
    Daniel EE; Kwan CY; Lee RM; Smeda J
    J Cardiovasc Pharmacol; 1984; 6 Suppl 4():S671-82. PubMed ID: 6083410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ion transport system in the smooth muscle and hypertension].
    Suzuki S; Kamouchi M; Kuriyama H
    Nihon Rinsho; 1992 Apr; 50 Suppl():422-9. PubMed ID: 1321921
    [No Abstract]   [Full Text] [Related]  

  • 31. Regulation of intracellular pH and its role in vascular smooth muscle function.
    Aalkjaer C
    J Hypertens; 1990 Mar; 8(3):197-206. PubMed ID: 2159500
    [No Abstract]   [Full Text] [Related]  

  • 32. Pathophysiological role of cation transport and natriuretic factors in hypertension.
    Haddy FJ; Pamnani MB; Clough DL
    Hypertension; 1987 Nov; 10(5 Pt 2):I101-7. PubMed ID: 2824358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is calcium more important than sodium in the pathogenesis of essential hypertension?
    McCarron DA
    Hypertension; 1985; 7(4):607-27. PubMed ID: 3891618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ionic channels of vascular smooth muscle in hypertension.
    Rusch NJ; Stekiel WJ
    Adv Exp Med Biol; 1991; 308():1-7. PubMed ID: 1724870
    [No Abstract]   [Full Text] [Related]  

  • 35. [Role of vascular reactivity and neuronal factors in the development of hypertension].
    Nara Y; Yamori Y
    Nihon Rinsho; 1989 Sep; 47(9):1934-40. PubMed ID: 2593266
    [No Abstract]   [Full Text] [Related]  

  • 36. A symposium: The calcium ion, cardiac myocyte and vascular smooth muscle in hypertension and its treatment. March 27-29, Nassau, the Bahamas.
    Am J Cardiol; 1987 Jan; 59(2):1A-121A. PubMed ID: 2433924
    [No Abstract]   [Full Text] [Related]  

  • 37. [Responsibility of the vascular system in the genesis of essential arterial hypertension].
    Worcel M
    Rev Prat; 1979 Dec; 29(55):4271-2, 4277-8, 4281. PubMed ID: 531455
    [No Abstract]   [Full Text] [Related]  

  • 38. Structure and mechanical properties of resistance arteries in hypertension: role of adhesion molecules and extracellular matrix determinants.
    Intengan HD; Schiffrin EL
    Hypertension; 2000 Sep; 36(3):312-8. PubMed ID: 10988257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is there a cellular abnormality in hypertension?
    Swales JD
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S39-44. PubMed ID: 1725041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The development and regression of vascular hypertrophy.
    Mulvany MJ
    J Cardiovasc Pharmacol; 1992; 19 Suppl 2():S22-7. PubMed ID: 1377300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.